Related Experiment Video
Updated: Aug 23, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Muscleblind proteins regulate alternative splicing
Thai H Ho1, Nicolas Charlet-B, Michael G Poulos
1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Abstract:
Although the muscleblind (MBNL) protein family has been implicated in myotonic dystrophy (DM), a specific function for these proteins has not been reported. A key feature of the RNA-mediated pathogenesis model for DM is the disrupted splicing of specific pre-mRNA targets. Here we demonstrate that MBNL proteins regulate alternative splicing of two pre-mRNAs that are misregulated in DM, cardiac troponin T (cTNT) and insulin receptor (IR). Alternative cTNT and IR exons are also regulated by CELF proteins, which were previously implicated in DM pathogenesis. MBNL proteins promote opposite splicing patterns for cTNT and IR alternative exons, both of which are antagonized by CELF proteins. CELF- and MBNL-binding sites are distinct and regulation by MBNL does not require the CELF-binding site. The results are consistent with a mechanism for DM pathogenesis in which expanded repeats cause a loss of MBNL and/or gain of CELF activities, leading to misregulation of alternative splicing of specific pre-mRNA targets.
Insights
Muscleblind (MBNL) proteins regulate alternative splicing of key genes, cardiac troponin T (cTNT) and insulin receptor (IR), which are misregulated in myotonic dystrophy (DM). This reveals a crucial role for MBNL proteins in DM RNA pathogenesis.
Area of Science:
- Molecular Biology
- Genetics
- RNA Biology
Background:
- The muscleblind (MBNL) protein family is linked to myotonic dystrophy (DM) pathogenesis.
- Disrupted pre-mRNA splicing is a hallmark of DM's RNA-mediated disease model.
- CELF proteins were previously implicated in DM pathogenesis and splicing regulation.
Purpose of the Study:
- To elucidate the specific function of MBNL proteins in DM.
- To investigate the role of MBNL proteins in the alternative splicing of DM-misregulated pre-mRNAs.
- To understand the interplay between MBNL and CELF proteins in regulating splicing.
Main Methods:
- Demonstrated MBNL protein regulation of cardiac troponin T (cTNT) and insulin receptor (IR) pre-mRNA alternative splicing.
- Investigated the antagonistic relationship between MBNL and CELF proteins on cTNT and IR splicing.
- Characterized distinct MBNL and CELF binding sites and MBNL's independence from CELF binding sites.
Main Results:
- MBNL proteins oppositely regulate alternative splicing of cTNT and IR exons.
- CELF proteins antagonize the splicing patterns promoted by MBNL for both cTNT and IR.
- MBNL regulation of splicing does not depend on the presence of CELF-binding sites.
Conclusions:
- MBNL proteins play a direct role in regulating alternative splicing of critical pre-mRNAs implicated in DM.
- The findings support a model where DM pathogenesis involves loss of MBNL and/or gain of CELF activity, disrupting splicing.
- This provides a mechanistic link between MBNL protein function and the RNA-mediated pathology of myotonic dystrophy.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
What is Gene Expression?

